L&C BIO Co.,LTD (KOSDAQ:290650)

Market Cap	1.09T -11.6%
Revenue (ttm)	116.30B +53.2%
Net Income	-149.41B
EPS	-2,990.48
Shares Out	53.94M
PE Ratio	n/a
Forward PE	13.70
Dividend	25.00 (0.12%)
Ex-Dividend Date	Dec 29, 2026

Volume	492,679
Open	21,000
Previous Close	21,450
Day's Range	20,100 - 22,000
52-Week Range	20,150 - 62,500
Beta	1.49
Analysts	Buy
Price Target	36,000.00 (+78.66%)
Est. Earnings	Feb 17, 2027

About L&C BIO Co.,LTD

L&C BIO Co.,LTD operates as a research and development company in tissue regeneration medicine. The company offers pharmaceuticals, human tissue, medical device, and cosmetics products. L&C BIO Co.,LTD was founded in 2011 and is headquartered in Seongnam-si, South Korea.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Employees: 183
• Stock Exchange: KOSDAQ
• Ticker Symbol: 290650

Analyst Summary

According to 2 analysts, the average rating for 290650 stock is "Buy." The 12-month stock price target is ₩36,000, which is an increase of 78.66% from the latest price.

Price Target

₩36,000

(78.66% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 13, 2026

Data Sources Report a data error